BAC
Bank of America Corporation
BAC has the edge over CIA overall, supported by stronger modeled upside and lower modeled downside.
CIA
Citizens, Inc.
CIA trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
CIA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
CIA's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CIA.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over CIA in the historical PE scenario, which offers more potential upside but is not a forecast.
CIA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.9x | $1.10 | -70% |
| Fair | 16x | $2.60 | -29% |
| Forward | 19x | $3.67 | — |
| Current | 23x | $3.67 | — |
| Expensive | 24x | $3.86 | +5.1% |
Historical ranges are pointers, not guarantees.
CIA's PE is in its expensive range at 23x. On analysts' estimates for next year's earnings, today's price would be 19x, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over CIA on the outlook, with more favorable earnings and revenue expectations.
CIA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect CIA's earnings and profitability to decline, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over CIA on earnings, with more consistent year-over-year improvement.
CIA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.19 | +19% |
| Q3 2026 | $0.16 | -24% |
| Q2 2026 | $0.21 | -4.5% |
| Q1 2026 | $0.35 | +106% |
| Q4 2025 | $0.28 | -3.4% |
| Q3 2025 | $0.21 | -51% |
| Q2 2025 | $0.22 | -49% |
| Q1 2025 | $0.17 | -64% |
| Q4 2024 | $0.29 | -40% |
CIA's earnings per share have fallen from their peak: $0.16 over the past year, against $0.48 in late 2023.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over CIA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over CIA on profitability, with a higher operating margin.
CIA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $65M | +3.6% |
| Q2 2026 | $60.4M | -7.2% |
| Q1 2026 | $59.7M | +7.3% |
| Q4 2025 | $72.1M | +14% |
| Q3 2025 | $62.8M | +1.7% |
| Q2 2025 | $65.1M | +4.8% |
| Q1 2025 | $55.7M | -3.6% |
| Q4 2024 | $63.5M | -5% |
CIA's revenue has picked up after four years of holding roughly level: $65M last quarter, up 3.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.2% | -6.9 points |
| Q2 2026 | -0.9% | -12 points |
| Q1 2026 | 4% | +7.2 points |
| Q4 2025 | 11% | +5.1 points |
| Q3 2025 | 7.1% | +2.2 points |
| Q2 2025 | 11% | +5.3 points |
| Q1 2025 | -3.2% | -12 points |
| Q4 2024 | 5.8% | -7.3 points |
CIA's operating margin was 0.2% last quarter, down 6.9 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over CIA on cash flow, with more consistent year-over-year improvement.
CIA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $10.7M | +132% |
| Q2 2026 | $2M | -39% |
| Q1 2026 | -$649K | -201% |
| Q4 2025 | $9M | -16% |
| Q3 2025 | $4.6M | -51% |
| Q2 2025 | $3.3M | -26% |
| Q1 2025 | $641K | -90% |
| Q4 2024 | $10.7M | +66% |
CIA's free cash flow was $21M over the past year, up 9.4% from the year before. Free cash flow isn't a meaningful measure for financial services companies like CIA.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over CIA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
CIA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +61.7K shares |
| 1 year | +0.8% | +408K shares |
| 3 years | +2.3% | +1.2M shares |
| 5 years | +0.5% | +248K shares |
CIA has 51M diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | $200,000 |
| Q3 2023 | — |
| Q1 2023 | — |
| Q4 2022 | $522,000 |
| Q4 2021 | — |
| Q3 2021 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
CIA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q4 2025 | -1.3x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -1.9x | Net Cash |
CIA has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
CIA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.7 | Neutral |
| Stochastic | 32.8 | Neutral |
CIA's weekly RSI is 41 (neutral) and its Stochastic is 33 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over CIA on valuation relative to its sector.
CIA PE vs Financial Services Sector
| Metric | CIA | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 13x | 76% above |
| PE % | 76 | 63 | 13 pts above |
CIA is trading at 23x earnings, a 76% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
CIA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.63 | 1.1% above |
| 20 week MA | $4.10 | 10% below |
| 50 week MA | $4.85 | 24% below |
| 100 week MA | $4.76 | 23% below |
| 200 week MA | $3.85 | 4.7% below |
CIA has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 4.7% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over CIA on returns for 2026, with the stronger performance.
CIA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.67 | $5.89 | -12% |
| 2021 | $5.89 | $5.76 | -2.2% |
| 2022 | $5.76 | $2.28 | -60% |
| 2023 | $2.28 | $2.69 | +18% |
| 2024 | $2.69 | $4.32 | +61% |
| 2025 | $4.32 | $5.16 | +19% |
| 2026 YTD | $5.16 | $3.67 | -29% |
CIA has finished lower in three of the last six years. It's down 29% so far in 2026.